Philadelphia is suing several pharmacy benefit managers and insulin manufacturers for allegedly inflating the price of the diabetes medication while falsely claiming they were working to lower prices.
Want more insights? Join Working Title - our career elevating newsletter and get the future of work delivered weekly.
